Age at menopause and lung function: a mendelian randomization study
File(s)revised2_Menopause_LF_earlyLATE_210619_supps_clean.docx (306.95 KB)
Supporting information
Author(s)
Type
Journal Article
Abstract
In observational studies, early menopause is associated with lower FVC and a higher risk of spirometric restriction, but not airflow obstruction. It is however unclear if this association is causal. We therefore used a Mendelian randomization (MR) approach, which is not affected by classical confounding, to assess the effect of age at natural menopause on lung function.
We included 94,742 naturally post-menopausal women from UK Biobank and performed MR analyses on the effect of age at menopause on FEV1, FVC, FEV1/FVC, spirometric restriction (FVC<LLN) and airflow obstruction (FEV1/FVC<LLN). We used the inverse variance-weighted (IVW) method, as well as methods that adjust for pleiotropy, and compared MR with observational analyses.
The MR analyses showed higher FEV1/FVC and a 15% lower risk of airflow obstruction for women with early (<45 years) compared to normal (45-55) menopause. Despite some evidence of pleiotropy, the results were consistent when using MR methods robust to pleiotropy. Similar results were found among never- and ever-smokers, while the protective effect seemed less strong in women ever using menopause hormone treatment and in overweight women. There was no strong evidence of association with FVC or spirometric restriction. In observational analyses of the same dataset, early menopause was associated with a pronounced reduction in FVC and a 13% higher spirometric restriction risk.
Our MR results suggest that early menopause has a protective effect on airflow obstruction. Further studies are warranted to better understand the inconsistency with observational findings, and to investigate the underlying mechanisms and role of female sex hormones.
We included 94,742 naturally post-menopausal women from UK Biobank and performed MR analyses on the effect of age at menopause on FEV1, FVC, FEV1/FVC, spirometric restriction (FVC<LLN) and airflow obstruction (FEV1/FVC<LLN). We used the inverse variance-weighted (IVW) method, as well as methods that adjust for pleiotropy, and compared MR with observational analyses.
The MR analyses showed higher FEV1/FVC and a 15% lower risk of airflow obstruction for women with early (<45 years) compared to normal (45-55) menopause. Despite some evidence of pleiotropy, the results were consistent when using MR methods robust to pleiotropy. Similar results were found among never- and ever-smokers, while the protective effect seemed less strong in women ever using menopause hormone treatment and in overweight women. There was no strong evidence of association with FVC or spirometric restriction. In observational analyses of the same dataset, early menopause was associated with a pronounced reduction in FVC and a 13% higher spirometric restriction risk.
Our MR results suggest that early menopause has a protective effect on airflow obstruction. Further studies are warranted to better understand the inconsistency with observational findings, and to investigate the underlying mechanisms and role of female sex hormones.
Date Issued
2019-10-01
Date Acceptance
2019-07-08
Citation
European Respiratory Journal, 2019, 54 (4), pp.1-10
ISSN
0903-1936
Publisher
European Respiratory Society
Start Page
1
End Page
10
Journal / Book Title
European Respiratory Journal
Volume
54
Issue
4
Copyright Statement
©ERS 2019 https://www.ersjournals.com/user-licence
Sponsor
Commission of the European Communities
Identifier
https://erj.ersjournals.com/content/54/4/1802421
Grant Number
633212
Subjects
Science & Technology
Life Sciences & Biomedicine
Respiratory System
ESTROGEN REPLACEMENT THERAPY
MULTIPLE GENETIC-VARIANTS
GENOME-WIDE ASSOCIATION
PULMONARY-FUNCTION
RESPIRATORY SYMPTOMS
POSTMENOPAUSAL
LOCI
SUSCEPTIBILITY
MENSTRUATION
CESSATION
Aged
Female
Forced Expiratory Volume
Humans
Lung
Mendelian Randomization Analysis
Menopause
Menopause, Premature
Middle Aged
Polymorphism, Single Nucleotide
Protective Factors
Pulmonary Disease, Chronic Obstructive
Vital Capacity
ALEC project
Lung
Humans
Pulmonary Disease, Chronic Obstructive
Menopause, Premature
Vital Capacity
Forced Expiratory Volume
Menopause
Polymorphism, Single Nucleotide
Aged
Middle Aged
Female
Mendelian Randomization Analysis
Protective Factors
11 Medical and Health Sciences
Respiratory System
Publication Status
Published
Date Publish Online
2019-10-17